TrialCirculation2019

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.

Subodh Verma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.